Colin Pritchard

FDA panel splits 6-4 on whether Grail's multi-cancer blood test works

The panel was unanimous that Grail's Galleri is safe and divided six to four on whether it is effective, on evidence in which 287 of more than 35,000 people screened got a cancer signal and about 60 percent of those were diagnosed.